Air India to tap Singapore Airlines to bolster fleet upkeep after June crash: Sources
NEW DELHI: Air India plans to lean on shareholder Singapore Airlines (SIA) to move some aircraft maintenance services in-house instead of outsourcing them to a state-owned company, according to people familiar with the matter.
The Indian airline is preparing to take on pre-flight and daily aircraft inspections, minor repair work and other troubleshooting activities from state-owned AI Engineering Services, or AIESL, said the people, who were not authorised to discuss the matter publicly.
SIA, which owns 25.1 per cent of Air India, will help in the transition of those maintenance tasks to the airline's staff, the people said.
'As a significant minority shareholder in Air India, Singapore Airlines has been working closely' to support Air India's transformation plan, an SIA spokesperson said in an e-mail. 'This includes providing our expertise and support to Air India, where necessary.'
The phased move away from AIESL follows a deadly crash on June 12 – the cause of which remains unknown, a sector-wide safety audit and a temporary safety-related pause in service.
Air India was in the midst of a transformation under its new owners – the Tata Group bought the unprofitable former state-run carrier in 2022 – when Flight AI171 crashed in the western city of Ahmedabad, killing all but one of the 242 people on board.
Gaining control of maintenance services was a part of Air India's restructuring plan even before the plane crash, but it had been put off in favour of getting more aircraft flying regularly and improving the experience aboard, the people said.
Concerns had been raised internally in the past as well about the service provided by AIESL – formerly a subsidiary when the carrier was state-owned – citing problems such as clogged toilets on flights, they said.
The Indian carrier 'continues to work closely with AIESL'. 'However, with our fleet expansion – 570 aircraft including a significant number of widebody jets – India's current MRO infrastructure is not equipped to support this scale,' an Air India spokesperson said in an e-mail. MRO refers to maintenance, repair and overhaul services.
'To meet the demands of our future operations and ensure world-class reliability and safety, we must invest in building robust MRO capabilities and capacity within the country,' the spokesperson added.
Air India's relationship with SIA in terms of assistance with aircraft maintenance comes full circle as it had been the one helping the Singapore-based airline during the 1970s.
Recent issues with Air India have also impacted SIA's earnings, contributing to a 59 per cent drop in profit for the quarter ended June 30.
The Air India plane crash also brought sharp scrutiny in the sector on issues like the maintenance of aircraft.
A recent audit report by the Indian Directorate-General of Civil Aviation showed Air India Group had the most issues among Indian carriers, according to an annual safety audit that began before the crash.
A total of 93 findings were reported for Air India as part of regular surveillance under a safety oversight programme, India's aviation regulator said on July 30. That far exceeded the 23 findings for rivals IndiGo and 14 for SpiceJet.
Air India has a fleet of 191 aircraft while its low-cost subsidiary – Air India Express – operates 115 planes, according to flight tracking website Flightradar24. The carriers fly a mix of Airbus and Boeing aircraft. - Bloomberg
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
6 minutes ago
- The Star
Saudi Aramco signs 11 bln USD lease-and-leaseback deal for Jafurah gas assets
RIYADH, Aug. 14 (Xinhua) -- Saudi Aramco announced Thursday the signing of an 11 billion U.S. dollar lease-and-leaseback agreement for its Jafurah gas processing assets with a consortium of international investors, marking a major inflow of foreign direct investment into the Kingdom's energy sector. The deal is led by funds managed by Global Infrastructure Partners (GIP), a part of New York-based global investment management corporation BlackRock, the company revealed in a statement. Jafurah is the largest non-associated gas development in Saudi Arabia. It is a key component in Aramco's plans to increase gas production capacity by 60 percent between 2021 and 2030, to meet rising demand. As part of the transaction, a newly-formed subsidiary, Jafurah Midstream Gas Company (JMGC), will lease development and usage rights for the Jafurah Field Gas Plant and the Riyas NGL Fractionation Facility, and lease them back to Aramco for 20 years. JMGC will receive a tariff payable by Aramco in exchange for granting Aramco the exclusive right to receive, process, and treat raw gas from Jafurah. Aramco will hold a 51 percent majority stake in JMGC, with the remaining 49 percent held by investors led by GIP. The transaction, which will not impose any restrictions on Aramco's production volumes, is expected to close as soon as practicable, subject to customary closing conditions.
The Star
31 minutes ago
- The Star
China pharma firms turn to local reagent suppliers to cut costs
PHARMACEUTICAL research and development firms in China are increasingly interested in procuring critical supplies known as reagents from local manufacturers, industry executives and managers say, as they seek to cut costs and delivery times. Western reagent suppliers including US-based Thermo Fisher Scientific and Germany's Merck have profited in the world's second-largest pharmaceutical market from the compounds used in lab tests for analysis and quality control. But rising Chinese import tariffs due to the trade war with the United States and longer-term concerns about costs or access are spurring Chinese companies to request products from local rivals like Shanghai Titan Scientific and Nanjing Vazyme Biotech instead, the executives and managers said. The five who spoke to Reuters work at Chinese firms involved in the purchase or supply of reagents and their comments are an early sign of an expected industry shift toward more Chinese purchases. China's reagent market for lab and diagnostic use has been to some extent supplied by imports, which were valued at US$5.76bil in 2024, down slightly from US$5.83bil in 2023, according to UN Comtrade data. 'It is actually more advantageous (for reagents to be local) because the timeliness requirement is high,' said Ma Xingquan, co-president of pharmaceutical research firm ChemPartner PharmaTech. Most reagents it uses in its pre-clinical work are products that are made in China by firms including Titan and Shanghai Aladdin Biochemical Technology, he said. ChemPartner's usage of locally made reagents would probably increase further as new products become available, Ma added. The rush to use domestically made reagents has accelerated since April, the month China raised duties on US goods to 125%, a manager at Titan and an executive at Vazyme said, though the levies have since been lowered as Beijing and Washington continue trade talks. Some Chinese drugmakers were worried about tariff policy uncertainty, Titan product manager Yang Dong said. Since April, more than 90% of Vazyme's customers have discussed replacing imported reagents with its products, Vazyme senior vice-president Xu Xiaoyu said. 'Before April, customers were only saying long term, they hope to be able to replace (reagents) with those locally made, it would be better,' Xu said. 'But to customers these tariffs are like a shock in a short period of time. They clearly felt this type of direct impact ... their impetus (for replacement) will be stronger.' Titan and Vazyme are both forecast to report strong sales growth this year, according to brokers. China International Capital Corp expects Titan's annual revenue to grow 22% to 3.52 billion yuan (US$490mil) this year, while Vazyme's revenue is set to rise 15% to 1.59 billion yuan over the same period, according to Soochow Securities. 'There is still a lot of room for substitution of imported biological reagent enzymes, clients are strongly interested in locally-made replacements,' Soochow said in a recent note. Shares in Titan and Vazyme have risen about 54% and 18% respectively since the start of the year. Merck and Thermo Fisher shares have fallen about 21% and 8% respectively over the same period. Morningstar analyst Max Jousma expects China's reagents market to grow more than 10% annually over the next five years, driven by government support for the biotech and pharmaceutical sectors and growth in research and development activity and in-vitro diagnostic testing. Merck and Swiss diagnostics group Roche Holding are moving some of their reagent production closer to their Chinese customers. In 2023, Merck announced plans to invest €70mil (US$81mil) in a reagents facility in Nantong that is on track to begin operations next year. Merck declined to comment on any short-term shifts in ordering patterns from Chinese customers. 'The decision to invest in reagent manufacturing in Nantong reflects our commitment to supporting the growing needs of life science and biopharma customers in China and the broader Asia-Pacific region,' it said in a statement. Roche is expanding production, laboratory and logistics facilities from 2028 in Suzhou, where it produces reagents for diagnostic systems, the company said in a statement. The expansion will help it meet increasing demand for diagnostic solutions in China and parts of Asia-Pacific, it said. — Reuters Andrew Silver writes for Reuters. The views expressed here are the writer's own.
The Star
an hour ago
- The Star
Apple looks beyond its existing products
LOS ANGELES: Apple Inc is plotting its artificial intelligence (AI) comeback with an ambitious slate of new devices, including robots, a lifelike version of Siri, a smart speaker with a display and home-security cameras. A tabletop robot that serves as a virtual companion, targeted for 2027, is the centrepiece of the AI strategy, according to people with knowledge of the matter. The smart speaker with a display, meanwhile, is slated to arrive next year, part of a push into entry-level smart-home products. Home security is seen as another big growth opportunity. New cameras will anchor an Apple security system that can automate household functions. The approach should help make Apple's product ecosystem stickier with consumers, said the people, who asked not to be identified because the initiatives haven't been announced. Apple shares climbed to a session high on Wednesday after Bloomberg News reported on the plans. The stock was up nearly 2% to US$233.70 in New York. It's all part of an effort to restore Apple's mojo. Its most recent moon-shot project, the Vision Pro headset, remains a sales flop, and the design of its bestselling devices has remained largely unchanged for years. At the same time, Apple has come under fire for missing the generative AI revolution. And OpenAI may even threaten the company's home turf by developing new AI-driven devices with the help of former Apple design chief Jony Ive. Though Apple is still in the early stages of turning around its AI software, executives see the pipeline of hardware as a key piece of its resurgence – helping it challenge Samsung Electronics Co, Meta Platforms Inc and others in new categories. A spokesperson for Cupertino, California-based Apple declined to comment. Because the products haven't been announced, the company's plans could still change or be scrapped. Many of the initiatives and their timelines rely on Apple's continued progress in AI-powered software. Chief executive officer Tim Cook told employees in an all-hands meeting this month that Apple must win in AI and hinted at the upcoming devices. 'The product pipeline – which I can't talk about – it's amazing, guys. It's amazing,' Cook said. 'Some of it you'll see soon. Some of it will come later. But there's a lot to see.' Beyond the home devices, Apple is preparing thinner and redesigned iPhones for release this year. And further out, it aims to introduce smart glasses, a foldable phone, a 20-year anniversary iPhone and a revamped headset dubbed N100. It's also planning a large foldable device that melds a MacBook and an iPad. Apple is looking to boost sales after years of slowing growth for its flagship products. It also nixed some expansions into new areas, like self-driving cars, adding pressure to find other sources of revenue. Moreover, the new initiatives will help rebut the idea that the company is no longer innovating like it used to. Bloomberg News first reported last year that Apple was moving forward with a tabletop robotics project, code-named J595, and developing a new smart-home strategy. But now a clearer picture is forming of its push into that market – and what it means for its AI ambitions. The tabletop robot resembles an iPad mounted on a movable limb that can swivel and reposition itself to follow users in a room. Like a human head, it can turn toward a person who is speaking or summoning it, and even seek to draw the attention of someone not facing it. The hope is to bring AI to life in ways that other hardware makers have yet to do. Apple imagines customers placing it on a desk or kitchen counter and using it to get work done, consume media and manage their day. FaceTime calls will also be a key function of the device. During videoconferencing, the display will be able to shift to lock on to people around a room. Apple is testing a feature that turns an iPhone screen into a joystick, letting users move around the robot to show different people or items in a room during video calls. But the hallmark of the device is an entirely new version of the Siri voice assistant that can inject itself into conversations between multiple people. It will be able to engage with users throughout the day and more easily recall information. The idea is for the device to act like a person in a room. It could interrupt a conversation between friends about dinner plans, say, and suggest nearby restaurants or relevant recipes. It's also being designed to engage in back-and-forth discussions for things like planning a trip or getting tasks done – similar to OpenAI's voice mode. Apple is planning to put Siri at the centre of the device operating system and give it a visual personality to make it feel lifelike. The approach, dubbed Bubbles, is vaguely reminiscent of Clippy, an animated paper clip from the 1990s that served as a virtual assistant in Microsoft Office. Apple has tested making Siri look like an animated version of the Finder logo, the iconic smiley face representing the Mac's file management system. A final decision on its appearance hasn't been made, with designers considering ideas that veer closer to Memoji, the playful characters that represent Apple user accounts. Device prototypes use a roughly seven-inch horizontal display, approaching the size of an iPad mini. The motorised arm can extend the display away from the base roughly half a foot in any direction. Some people familiar with the product call it the 'Pixar Lamp', referring to the animated film company's famous logo. Apple has previously disclosed some research in this area: It published a paper in January detailing a light fixture that uses robotics to move around. Apple has multiple teams across its AI, hardware, software and interface design groups tackling the project. The work is being led in part by Kevin Lynch, who previously oversaw a push into smart watch software and cars. The technology giant is developing several other robots. It has teams exploring a mobile bot with wheels – something akin to Inc's Astro – and has loosely discussed humanoid models. Apple has a group actively developing a large mechanical arm for use in manufacturing facilities or handling tasks in the back of retail stores, a move that could potentially replace some staff. Such a robot, code-named T1333, remains several years away. — Bloomberg
